» Articles » PMID: 31345963

How Different Are COPD-specific Patient Reported Outcomes, Health Status, Dyspnoea and Respiratory Symptoms? An Observational Study in a Working Population

Overview
Journal BMJ Open
Specialty General Medicine
Date 2019 Jul 27
PMID 31345963
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: We hypothesised that chronic obstructive pulmonary disease (COPD)-specific health status measured by the COPD assessment test (CAT), respiratory symptoms by the evaluating respiratory symptoms in COPD (E-RS) and dyspnoea by Dyspnoea-12 (D-12) are independently based on specific conceptual frameworks and are not interchangeable. We aimed to discover whether health status, dyspnoea or respiratory symptoms could be related to smoking status and airflow limitation in a working population.

Design: This is an observational, cross-sectional study.

Participants: 1566 healthy industrial workers were analysed.

Results: Relationships between D-12, CAT and E-RS total were statistically significant but weak (Spearman's correlation coefficient=0.274 to 0.446). In 646 healthy non-smoking subjects, as the reference scores for healthy non-smoking subjects, that is, upper threshold, the bootstrap 95th percentile values were 1.00 for D-12, 9.88 for CAT and 4.44 for E-RS. Of the 1566 workers, 85 (5.4%) were diagnosed with COPD using the fixed ratio of the forced expiratory volume in one second/forced vital capacity <0.7, and 34 (2.2%) using the lower limit of normal. The CAT and E-RS total were significantly worse in non-COPD smokers and subjects with COPD than non-COPD never smokers, although the D-12 was not as sensitive. There were no significant differences between non-COPD smokers and subjects with COPD on any of the measures.

Conclusions: Assessment of health status and respiratory symptoms would be preferable to dyspnoea in view of smoking status and airflow limitation in a working population. However, these patient-reported measures were inadequate in differentiating between smokers and subjects with COPD identified by spirometry.

Citing Articles

Association between healthy lifestyles and post-COVID-19 syndrome among college students.

Sun D, Zhu X, Bao Z, Lin X Ann Thorac Med. 2024; 19(2):139-146.

PMID: 38766372 PMC: 11100468. DOI: 10.4103/atm.atm_219_23.


The Conceptual Independence of Health Status, Respiratory Symptoms and Dyspnea in Chronic Obstructive Pulmonary Disease in Real Clinical Practice.

Nishimura K, Kusunose M, Mori M, Shibayama A, Nakayasu K Diagnostics (Basel). 2023; 13(15).

PMID: 37568855 PMC: 10417120. DOI: 10.3390/diagnostics13152492.


Efficacy and safety of once-daily single-inhaler triple therapy for mild-to-moderate chronic obstructive pulmonary disease: a study protocol for a randomised and interventional study.

Takahashi K, Kawayama T, Takamori A, Tashiro H, Kinoshita T, Takagi K BMJ Open Respir Res. 2023; 10(1).

PMID: 37197795 PMC: 10441813. DOI: 10.1136/bmjresp-2022-001607.


Computation of the distribution of model accuracy statistics in machine learning: Comparison between analytically derived distributions and simulation-based methods.

Huang A, Huang S Health Sci Rep. 2023; 6(4):e1214.

PMID: 37091362 PMC: 10119581. DOI: 10.1002/hsr2.1214.


Relationship Between Clinical Control, Respiratory Symptoms and Quality of Life for Patients with COPD.

Alcazar-Navarrete B, Fuster A, Garcia Sidro P, Garcia Rivero J, Abascal-Bolado B, Pallares-Sanmartin A Int J Chron Obstruct Pulmon Dis. 2020; 15:2683-2693.

PMID: 33149566 PMC: 7604255. DOI: 10.2147/COPD.S265470.

References
1.
Gupta N, Pinto L, Morogan A, Bourbeau J . The COPD assessment test: a systematic review. Eur Respir J. 2014; 44(4):873-84. DOI: 10.1183/09031936.00025214. View

2.
Price D, Tinkelman D, Halbert R, Nordyke R, Isonaka S, Nonikov D . Symptom-based questionnaire for identifying COPD in smokers. Respiration. 2005; 73(3):285-95. DOI: 10.1159/000090142. View

3.
Jones P, Chen W, Wilcox T, Sethi S, Leidy N . Characterizing and quantifying the symptomatic features of COPD exacerbations. Chest. 2010; 139(6):1388-1394. DOI: 10.1378/chest.10-1240. View

4.
Gnanasakthy A, Mordin M, Evans E, Doward L, DeMuro C . A Review of Patient-Reported Outcome Labeling in the United States (2011-2015). Value Health. 2017; 20(3):420-429. DOI: 10.1016/j.jval.2016.10.006. View

5.
Oga T, Nishimura K, Tsukino M, Sato S, Hajiro T . Analysis of the factors related to mortality in chronic obstructive pulmonary disease: role of exercise capacity and health status. Am J Respir Crit Care Med. 2002; 167(4):544-9. DOI: 10.1164/rccm.200206-583OC. View